Notably, in this setting recent studies are focusing on the CSF liquid biopsy as a useful tool in case of massive and rapid progression in order to redefine the biology of the tumor and to overcome the resistance by the switch to another adequate ALK inhibitor [51,86,87,88,89,90,91]. This evidence concerns the gene ALK and neoplasm.